The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Kappa Opioid System in Nucleus Accumbens Drives Pain-Induced Negative Affect | Pain Research Forum
Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography | Translational Psychiatry
Major Depressive Disorder and Kappa Opioid Receptor
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Antagonists of the kappa opioid receptor - ScienceDirect
Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities | HTML
Dynorphin, stress, and depression | Semantic Scholar
Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology | PLOS ONE
Sex Differences in Sensitivity to the Depressive-like Effects of the Kappa Opioid Receptor Agonist U-50488 in Rats - Biological Psychiatry
PDF) Antidepressant-Like Effects of the Novel Kappa Opioid Antagonist MCL-144B in the Forced-Swim Test | John Neumeyer - Academia.edu
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Mu Opioid Receptor Antagonists: Recent Developments - Goodman - 2007 - ChemMedChem - Wiley Online Library
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Physiology and Pharmacology of Opioid Analgesics | Basicmedical Key
Major Depressive Disorder and Kappa Opioid Receptor
PDF) Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Structure–Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin | Journal of Medicinal Chemistry
κ-opioid receptor - Wikipedia
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Development of κ opioid receptor antagonists. | Semantic Scholar
